These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 37630458)

  • 41. Probiotics: A Promising Candidate for Management of Colorectal Cancer.
    Tripathy A; Dash J; Kancharla S; Kolli P; Mahajan D; Senapati S; Jena MK
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients' Stratification.
    Ionica E; Gaina G; Tica M; Chifiriuc MC; Gradisteanu-Pircalabioru G
    Front Oncol; 2021; 11():811486. PubMed ID: 35198435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut Microbiota Eubacterium callanderi Exerts Anti-Colorectal Cancer Activity.
    Ryu SW; Kim JS; Oh BS; Choi WJ; Yu SY; Bak JE; Park SH; Kang SW; Lee J; Jung WY; Lee JS; Lee JH
    Microbiol Spectr; 2022 Dec; 10(6):e0253122. PubMed ID: 36448791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of the Polyphenol-Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer.
    Zhao Y; Jiang Q
    Adv Nutr; 2021 Mar; 12(2):546-565. PubMed ID: 32905583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer.
    Lu L; Dong J; Liu Y; Qian Y; Zhang G; Zhou W; Zhao A; Ji G; Xu H
    Front Pharmacol; 2022; 13():964793. PubMed ID: 36046819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 48. Supplementation of quinoa peptides alleviates colorectal cancer and restores gut microbiota in AOM/DSS-treated mice.
    Fan X; Guo H; Teng C; Yang X; Qin P; Richel A; Zhang L; Blecker C; Ren G
    Food Chem; 2023 May; 408():135196. PubMed ID: 36535178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy.
    Gomes S; Baltazar F; Silva E; Preto A
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects.
    Li J; Zhang AH; Wu FF; Wang XJ
    Front Oncol; 2022; 12():841552. PubMed ID: 35223525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications.
    Gomes SD; Oliveira CS; Azevedo-Silva J; Casanova MR; Barreto J; Pereira H; Chaves SR; Rodrigues LR; Casal M; Côrte-Real M; Baltazar F; Preto A
    Curr Med Chem; 2020; 27(24):4087-4108. PubMed ID: 29848266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.
    Yixia Y; Sripetchwandee J; Chattipakorn N; Chattipakorn SC
    Anaerobe; 2021 Apr; 68():102361. PubMed ID: 33781900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
    Singh D; Khan MA; Siddique HR
    Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lactobacillus coryniformis MXJ32 administration ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated colorectal cancer via reshaping intestinal microenvironment and alleviating inflammatory response.
    Wang T; Zhang L; Wang P; Liu Y; Wang G; Shan Y; Yi Y; Zhou Y; Liu B; Wang X; Lü X
    Eur J Nutr; 2022 Feb; 61(1):85-99. PubMed ID: 34185157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors' Combination.
    Quesada-Vázquez S; Bone C; Saha S; Triguero I; Colom-Pellicer M; Aragonès G; Hildebrand F; Del Bas JM; Caimari A; Beraza N; Escoté X
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The double-edged sword of probiotic supplementation on gut microbiota structure in
    Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
    Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model.
    Dos Santos Cruz BC; da Silva Duarte V; Giacomini A; Corich V; de Paula SO; da Silva Fialho L; Guimarães VM; de Luces Fortes Ferreira CL; Gouveia Peluzio MDC
    Appl Microbiol Biotechnol; 2020 Oct; 104(20):8837-8857. PubMed ID: 32902682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.